Assessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to Adalimumab

Jennifer Liu, Tamer Eris, Cynthia Li, Shawn Cao, Scott Kuhns

BioDrugs · 2016 · 97 citations · 25 references

DOIFull text

Open access

Abstract

Based on the comprehensive analytical similarity assessment, ABP 501 was found to be similar to adalimumab with respect to physicochemical and biological properties.

References

25